Best of #econtwitter - Week of June 19, 2022 [3/3]
Welcome readers old and new to this week’s edition of Best of Econtwitter. Thanks to those sharing suggestions, over email or on Twitter @just_economics.
This is part three of three.
Paper summaries
Poorer children show cognitive fatigue faster than richer ones, and attend schools that give fewer chances to build attentional capacity. But this can be improved with simple changes at school--as we show in our Cognitive Endurance paper. Summary below! @christinalbrown @h_schof
Christina Brown @christinalbrown
BUT how much cognitive decline people suffer varies enormously and, across the variety of settings we look at (work, voting, school), low SES individuals exhibit much larger declines. 3/
New NBER wp: Many diff-in-diff papers use state level laws, but what do we know about those? Two key facts. From 1950s to 90s, best predictor of law adoption is adoption by geographic neighbors. Last 20 yrs, best predictor is adoption by politically aligned states #polarization
NBER @nberpubs
Friends and students occasionally ask me about the genesis of my 2005 QJE paper with Marc Melitz on “International Trade and Macroeconomic Dynamics with Heterogeneous Firms.” Here is the story, for anyone who may be interested. 1/n
Happy Friday, #Econtwitter! My paper with @drewkoke and @jj_eugene_tan is forthcoming at AEJ: Macro! 🎉
We study the short-term effects of an import-competition shock on capital reallocation and aggregate productivity in the domestic economy.
What do we find? A 🧵...
AEA Journals @AEAjournals
@RevEconStudies @SNageebAli @PennStateEcon @econ_greg @MSFTResearch @StanfordGSB @nberpubs A few years ago, I wrote a thread introducing a paper on "Voluntary Disclosure & Personalized Pricing" with @SNageebAli and @econ_greg (threadreaderapp.com/thread/1186778…).
Now that the paper has been accepted for publication, an update on what the paper is about 👇 1/n
I hadn't re-read this paper in a while, it's an absolute banger: joshgraffzivin.com/s/NIH-Patents_…
NIH grants lead to ~just as many patents on diseases that aren't what they were focused on as what they were.
This is a very grim presentation on the status of biomedical research in America by one of the world experts on how science gets done. Institutional decay among our health agencies (visible during COVID) is slowing progress, philanthropy is helping, but more needs to be done.
Pierre Azoulay @pierre_azoulay
Interesting discussions
The number of Americans with disabilities is up by about 2 million since before the pandemic. Wonder why that is? bloomberg.com/opinion/articl…
The disability increase has been driven mostly by people saying they're having "serious difficulty concentrating, remembering, or making decisions." And, yeah, it's tough to concentrate these days. But that also sounds like it could be Long Covid bloomberg.com/opinion/articl…
JoE story is even more interesting. 1971 AEA resolution that established CSWEP had provisions for the creation of "open listing of all employment opportunities” Galbraith contemplated setting up a joint CSWEP/hiring practices committee, but latter was chaired by Ray Marshall...
Stephan Lefebvre @LefebvreEcon
Great question. I have found a few types of mentorship useful.
A lot is similar to what a grad advisor does, but just because we got a PhD doesn’t mean we’re fully-baked!
It may sound like a lot but not all of these “services” have to be by the same person…1/N
Gordon Hanson @gordon_h_hanson